Wealthfront Advisers LLC United Therapeutics Corp Transaction History
Wealthfront Advisers LLC
- $120 Billion
- Q4 2024
A detailed history of Wealthfront Advisers LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 18,314,300 shares of UTHR stock, worth $6.56 Billion. This represents 5.38% of its overall portfolio holdings.
Number of Shares
18,314,300
Previous 876
2090573.52%
Holding current value
$6.56 Billion
Previous $313,000
2064442.17%
% of portfolio
5.38%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.59 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$989 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$883 Million0.16% of portfolio
-
State Street Corp Boston, MA2.2MShares$788 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...